Pascal KraftJan 311 minIn the NewsDrug Discovery & DevelopmentYmmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...
Pascal KraftJan 131 minIn the NewsFierce Biotech: Appointment of Michel JanicotMichel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...
Pascal KraftJun 14, 20221 minIn the NewsBioPharma DiveYmmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...
Pascal KraftApr 11, 20221 minIn the NewsPharmTechYmmunobio AG Signs Patent Purchase Agreement with LeukoGmbH https://www.pharmtech.com/view/ymmunobio-ag-signs-patent-purchase-agreement-w...